Cargando…

Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation

Detalles Bibliográficos
Autores principales: Lee, Yueh-Lun, Chen, Chih-Wei, Liu, Fu-Hwa, Huang, Yu-Wen, Huang, Huei-Mei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636156/
https://www.ncbi.nlm.nih.gov/pubmed/29020096
http://dx.doi.org/10.1371/journal.pone.0186528
_version_ 1783270397809000448
author Lee, Yueh-Lun
Chen, Chih-Wei
Liu, Fu-Hwa
Huang, Yu-Wen
Huang, Huei-Mei
author_facet Lee, Yueh-Lun
Chen, Chih-Wei
Liu, Fu-Hwa
Huang, Yu-Wen
Huang, Huei-Mei
author_sort Lee, Yueh-Lun
collection PubMed
description
format Online
Article
Text
id pubmed-5636156
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-56361562017-10-30 Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation Lee, Yueh-Lun Chen, Chih-Wei Liu, Fu-Hwa Huang, Yu-Wen Huang, Huei-Mei PLoS One Correction Public Library of Science 2017-10-11 /pmc/articles/PMC5636156/ /pubmed/29020096 http://dx.doi.org/10.1371/journal.pone.0186528 Text en © 2017 Lee et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Correction
Lee, Yueh-Lun
Chen, Chih-Wei
Liu, Fu-Hwa
Huang, Yu-Wen
Huang, Huei-Mei
Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation
title Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation
title_full Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation
title_fullStr Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation
title_full_unstemmed Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation
title_short Correction: Aclacinomycin A Sensitizes K562 Chronic Myeloid Leukemia Cells to Imatinib through p38MAPK-Mediated Erythroid Differentiation
title_sort correction: aclacinomycin a sensitizes k562 chronic myeloid leukemia cells to imatinib through p38mapk-mediated erythroid differentiation
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636156/
https://www.ncbi.nlm.nih.gov/pubmed/29020096
http://dx.doi.org/10.1371/journal.pone.0186528
work_keys_str_mv AT leeyuehlun correctionaclacinomycinasensitizesk562chronicmyeloidleukemiacellstoimatinibthroughp38mapkmediatederythroiddifferentiation
AT chenchihwei correctionaclacinomycinasensitizesk562chronicmyeloidleukemiacellstoimatinibthroughp38mapkmediatederythroiddifferentiation
AT liufuhwa correctionaclacinomycinasensitizesk562chronicmyeloidleukemiacellstoimatinibthroughp38mapkmediatederythroiddifferentiation
AT huangyuwen correctionaclacinomycinasensitizesk562chronicmyeloidleukemiacellstoimatinibthroughp38mapkmediatederythroiddifferentiation
AT huanghueimei correctionaclacinomycinasensitizesk562chronicmyeloidleukemiacellstoimatinibthroughp38mapkmediatederythroiddifferentiation